SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
- 20 August 2011
- journal article
- guideline
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (8) , 545-551
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Updated safety and efficacy results of the phase III trial of sunitinib (SU) versus placebo (PBO) for treatment of pancreatic neuroendocrine tumors (NET).Journal of Clinical Oncology, 2010
- Systemic therapy for neuroendocrine tumours of gastroenteropancreatic originEndocrine-Related Cancer, 2010
- Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)Annals of Oncology, 2010
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study GroupJournal of Clinical Oncology, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and SurvivalJournal of Clinical Oncology, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO ClassificationAnnals of the New York Academy of Sciences, 2004